US2011177121A1PendingUtilityA1
Immunogenic Influenza Composition
Est. expiryFeb 21, 2028(~1.6 yrs left)· nominal 20-yr term from priority
A61K 39/12A61K 2039/53A61K 39/145A61K 2039/525A61K 2039/5258A61K 2039/55566C12N 2760/16134A61P 37/04A61K 2039/5252A61P 31/16
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel compositions useful as influenza immunogens are provided. The compositions enable a host response to immunogen sites normally not recognized by a host.
Claims
exact text as granted — not AI-modified1 . An isolated composition comprising an immunogenic epitope of influenza that is not immunodominant as in a wild type virus.
2 . The composition of claim 1 comprising a hemagglutinin.
3 . The composition of claim 1 comprising a neuraminidase.
4 . The composition of claim 1 comprising an influenza virus particle.
5 . The composition of claim 4 , wherein said particle is inactivated.
6 . The composition of claim 1 wherein said composition comprises addition or removal of a glycosylation site.
7 . The composition of claim 1 , wherein said composition comprises an amino acid addition, substitution or deletion.
8 . The composition of claim 1 comprising a virus-like particle.
9 . The composition of claim 1 expressed on the surface of influenza virus.
10 . The composition of claim 1 , further comprising a pharmaceutically acceptable carrier, diluent or excipient.Join the waitlist — get patent alerts
Track US2011177121A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.